Lumos Pharma, Inc. (LUMO)
NASDAQ
Market Cap
$18.3M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
645 of 809
Rank in Industry
351 of 445
Largest Insider Buys in Sector
LUMO Stock Price History Chart
LUMO Stock Performance
About Lumos Pharma, Inc.
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
Insider Activity of Lumos Pharma, Inc.
Over the last 12 months, insiders at Lumos Pharma, Inc. have bought $0 and sold $10,919 worth of Lumos Pharma, Inc. stock.
On average, over the past 5 years, insiders at Lumos Pharma, Inc. have bought $1.52M and sold $867,588 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $20,120 was made by McCracken Joseph S (director) on 2022‑11‑16.
List of Insider Buy and Sell Transactions, Lumos Pharma, Inc.
| 2023-08-02 | Sale | McKew John C. | Chief Scientific Officer | 3,407 0.0418% | $3.21 | $10,919 | -8.54% | |
| 2023-04-04 | Sale | McKew John C. | Chief Scientific Officer | 2,214 0.027% | $3.27 | $7,240 | -3.74% | |
| 2023-02-02 | Sale | McKew John C. | Chief Scientific Officer | 439 0.0054% | $3.53 | $1,550 | -5.49% | |
| 2022-11-16 | McCracken Joseph S | director | 4,000 0.0494% | $5.03 | $20,120 | -29.42% | ||
| 2022-09-23 | Hawkins Richard J | Chief Executive Officer | 208 0.0024% | $8.80 | $1,830 | -61.56% | ||
| 2022-09-21 | Hawkins Richard J | Chief Executive Officer | 2,214 0.0264% | $8.84 | $19,572 | -60.70% | ||
| 2022-09-20 | Hawkins Richard J | Chief Executive Officer | 1,506 0.0178% | $8.75 | $13,178 | -60.59% | ||
| 2022-09-19 | Hawkins Richard J | Chief Executive Officer | 541 0.0064% | $8.65 | $4,680 | -59.77% | ||
| 2021-09-08 | Sale | McKew John C. | Chief Scientific Officer | 2,214 0.027% | $11.30 | $25,018 | -23.62% | |
| 2021-09-08 | LALANDE KEVIN M. | director | 10,000 0.121% | $11.21 | $112,116 | -23.62% | ||
| 2021-09-07 | LALANDE KEVIN M. | director | 10,000 0.1194% | $11.11 | $111,139 | -23.97% | ||
| 2021-09-03 | LALANDE KEVIN M. | director | 8,100 0.0969% | $11.35 | $91,905 | -25.37% | ||
| 2021-09-02 | LALANDE KEVIN M. | director | 6,300 0.0745% | $11.23 | $70,739 | -25.35% | ||
| 2021-09-01 | LALANDE KEVIN M. | director | 4,589 0.0546% | $10.87 | $49,892 | -22.19% | ||
| 2021-08-31 | LALANDE KEVIN M. | director | 6,000 0.0708% | $10.70 | $64,181 | -21.61% | ||
| 2021-08-30 | LALANDE KEVIN M. | director | 8,625 0.1023% | $10.52 | $90,738 | -19.60% | ||
| 2021-08-27 | LALANDE KEVIN M. | director | 4,981 0.0595% | $10.50 | $52,282 | -18.73% | ||
| 2021-08-26 | LALANDE KEVIN M. | director | 6,200 0.0736% | $10.07 | $62,430 | -15.76% | ||
| 2021-08-25 | LALANDE KEVIN M. | director | 14,900 0.1769% | $9.87 | $147,078 | -14.07% | ||
| 2021-08-24 | LALANDE KEVIN M. | director | 10,775 0.1275% | $9.45 | $101,871 | -10.41% |
Insider Historical Profitability
<0.0001%
| McKew John C. | Chief Scientific Officer | 18707 0.2364% | $2.26 | 0 | 4 | |
| Stine Seed Farm, Inc. | 10 percent owner | 7857732 99.2817% | $2.26 | 3 | 0 | +18.87% |
| Flynn James E | 10 percent owner | 784568 9.9129% | $2.26 | 0 | 3 | |
| LALANDE KEVIN M. | director | 730446 9.2291% | $2.26 | 19 | 0 | <0.0001% |
| Link Charles J. Jr. | Chairman of the Board and CEO | 282756 3.5726% | $2.26 | 1 | 68 | <0.0001% |
| Lundquist David J. | director | 87630 1.1072% | $2.26 | 1 | 0 | +62.86% |
| Vahanian Nicholas N. | President, Chief Medical Offic | 65284 0.8249% | $2.26 | 0 | 22 | |
| Raffin Thomas A. | director | 62659 0.7917% | $2.26 | 0 | 1 | |
| HENNEMAN JOHN B III | EVP, Chief Financial Officer | 62316 0.7874% | $2.26 | 2 | 1 | +9.95% |
| Talarico Ernest III | director | 32223 0.4071% | $2.26 | 1 | 4 | +0.57% |
| Ramsey William J. | Quality Assurance Officer | 32146 0.4062% | $2.26 | 0 | 21 | |
| Wiley Brian | VP of Business Development | 19942 0.252% | $2.26 | 0 | 9 | |
| Langren Carl W. | Principal Accounting Officer | 19666 0.2485% | $2.26 | 0 | 6 | |
| Saluri Joseph | director | 16048 0.2028% | $2.26 | 0 | 2 | |
| McCracken Joseph S | director | 15721 0.1986% | $2.26 | 2 | 0 | <0.0001% |
| LINK GORDON H JR | Chief Financial Officer | 14413 0.1821% | $2.26 | 0 | 13 | |
| Hawkins Richard J | Chief Executive Officer | 4469 0.0565% | $2.26 | 4 | 0 | <0.0001% |
| Schuchart Aaron | Chief Business Officer | 3037 0.0384% | $2.26 | 2 | 0 | +12.07% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Wells Fargo | $1.17M | 5.12 | 415,551 | -0.36% | -$4,230.00 | <0.0001 | |
| Goldman Sachs | $1.15M | 5.01 | 406,612 | 0% | +$2.82 | <0.0001 | |
| The Vanguard Group | $688,311.00 | 3.01 | 244,082 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $615,000.00 | 2.69 | 218,014 | -1.62% | -$10,155.31 | <0.01 | |
| Acuitas Investments, LLC | $396,743.00 | 1.73 | 140,689 | +12.3% | +$43,447.74 | 0.21 | |
| Jefferies Financial Group | $340,236.00 | 1.49 | 120,651 | 0% | +$0 | 0.01 | |
| Lion Point Capital LP | $256,039.00 | 1.12 | 90,794 | 0% | +$0 | 0.5 | |
| Blackstone | $221,720.00 | 0.97 | 78,624 | -75.92% | -$699,157.97 | <0.01 | |
| Greenwich Wealth Management, LLC | $215,000.00 | 0.94 | 76,341 | 0% | +$0 | 0.02 | |
| Geode Capital Management | $134,247.00 | 0.59 | 47,596 | 0% | +$0 | <0.0001 | |
| BlackRock | $115,913.00 | 0.51 | 41,104 | -5.42% | -$6,643.90 | <0.0001 | |
| Two Sigma | $109,464.00 | 0.48 | 38,817 | -8.92% | -$10,721.65 | <0.0001 | |
| Millennium Management LLC | $105,973.00 | 0.46 | 37,579 | New | +$105,973.00 | <0.0001 | |
| Two Sigma Advisers LP | $89,958.00 | 0.39 | 31,900 | +12.72% | +$10,152.00 | <0.0001 | |
| Dimensional Fund Advisors | $83,519.00 | 0.37 | 29,617 | +90.29% | +$39,629.01 | <0.0001 | |
| Bridgeway Capital Management | $77,953.00 | 0.34 | 27,643 | -41.98% | -$56,399.81 | <0.01 | |
| Tealwood Asset Management | $72,644.00 | 0.32 | 25,760 | 0% | +$0 | 0.02 | |
| Envestnet Asset Management Inc | $45,444.00 | 0.2 | 16,115 | +34.94% | +$11,767.78 | <0.0001 | |
| Private Advisor Group | $45,157.00 | 0.2 | 16,013 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $37,467.00 | 0.16 | 13,286 | New | +$37,467.00 | <0.0001 | |
| BNY Mellon | $33,438.00 | 0.15 | 11,858 | 0% | +$0 | <0.0001 | |
| Wealth Advisors of Iowa | $32,991.00 | 0.14 | 11,699 | 0% | +$0 | 0.02 | |
| State Street | $31,688.00 | 0.14 | 11,237 | 0% | +$0 | <0.0001 | |
| Key Financial, Inc. | $30,814.00 | 0.14 | 10,927 | 0% | +$0 | 0.01 | |
| Paladin Advisory Group Llc | $12,459.00 | 0.05 | 4,387 | 0% | +$0 | 0.01 | |
| UBS | $10,527.00 | 0.05 | 3,733 | +4,944.6% | +$10,318.32 | <0.0001 | |
| Tower Research Capital | $7,589.00 | 0.03 | 2,691 | +70.97% | +$3,150.10 | <0.0001 | |
| Bank of America | $5,076.00 | 0.02 | 1,800 | 0% | +$0 | <0.0001 | |
| West Financial Advisors LLC | $2,211.00 | 0.01 | 784 | 0% | +$0 | <0.01 | |
| Advisor Group Holdings Inc | $435.00 | <0.01 | 154 | -96.66% | -$12,586.75 | <0.0001 | |
| Morgan Stanley | $468.00 | <0.01 | 166 | 0% | +$0 | <0.0001 | |
| Group One Trading | $423.00 | <0.01 | 150 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $116.00 | <0.01 | 41 | +7.89% | +$8.49 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 78 | 0% | +$0 | <0.0001 | |
| GRP Financial | $31.00 | <0.01 | 11 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $8.00 | <0.01 | 3 | 0% | +$0 | <0.0001 |